Posted inWire
Merck to acquire Cidara Therapeutics for $9.2 billion
SAN DIEGO - Merck & Co Inc (NYSE: MRK), known as MSD outside the U.S. and Canada, said on Saturday it will acquire Cidara Therapeutics Inc (Nasdaq: CDTX) in a…
Posted inWire
AI Technology Group to acquire AVM Biotechnology
SEATTLE: AI Technology Group Inc. (OTCID: AIPG) said Friday it has filed an amended Form 10 with the U.S. Securities and Exchange Commission and signed a definitive agreement to acquire…
Posted inWire
Bristol Myers Squibb signs deal to acquire Orbital Therapeutics for $1.5 billion
NEW YORK: Bristol Myers Squibb (NYSE: BMY, BMS) and Orbital Therapeutics have entered into a definitive agreement in which BMS will acquire Orbital, a privately held biotech firm at the…
Posted inWire
Novo Nordisk to buy Akero for up to $5.2 billion
COPENHAGEN: Danish drugmaker Novo Nordisk will acquire U.S.-based Akero Therapeutics (AKRO.O) for up to $5.2 billion, gaining a promising liver disease treatment in the first major deal by its new chief…
Posted inLondon Stock Exchange
Roquefort Therapeutics to acquire Coiled Therapeutics in £30 million reverse takeover
LONDON: Roquefort Therapeutics plc (LSE:ROQ), a Main Market-listed biotech firm, said Monday it has entered into a binding term sheet to acquire Coiled Therapeutics, Inc., a clinical-stage oncology company spun…